Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pathology Analysis & Statistics, April 2014

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

1-50 of about 409 000 reports
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked ...

  • Industries : Pathology
  • Countries : World
HIV -- KOL Insight and Consensus Outlook Modules

HIV -- KOL Insight and Consensus Outlook Modules

  • $ 8 056
  • Industry report
  • February 2014
  • by Firstword Pharma

What do frontline clinicians really think about current HIV treatment pathways and what are the most pressing unmet needs that industry can respond to? What's driving long term growth in HIV? The market ...

  • Industries : Pathology
  • Countries : United States
Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...

  • Industries : Pathology
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, United Kingdom, Europe
Drugs for Treating Systemic Lupus Erythematosus: Global Markets

Drugs for Treating Systemic Lupus Erythematosus: Global Markets

  • $ 6 650
  • Industry report
  • March 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%. ...

  • Industries : Pathology
  • Countries : World
Neurostimulation: Technologies and Global Markets

Neurostimulation: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • March 2014
  • by BCC Research

REPORT HIGHLIGHTS The global neurostimulation devices market is expected to reach $3.8 billion in 2013 and $4.1 billion in 2018, with a compound annual growth rate (CAGR) of 1.5%. This report provides: ...

  • Industries : Pathology
  • Countries : World
Digital Pathology: Technologies and Global Markets

Digital Pathology: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • February 2014
  • by BCC Research

REPORT HIGHLIGHTS The global digital pathology market totaled nearly $2.1 billion in 2012. This market is expected to grow at a compound annual growth rate (CAGR) of 14.7% from $2.2 billion in 2013 to ...

  • Industries : Pathology
  • Countries : World
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

  • $ 5 995
  • Industry report
  • March 2014
  • by Global Data

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the ...

  • Industries : Pathology
  • Countries : United States, World, Europe, Spain, Italy, France, Germany
Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight

Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight

  • $ 5 619
  • Industry report
  • April 2014
  • by Firstword Pharma

Approval of Gilead's once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in class ...

  • Industries : Pathology
  • Countries : United States
Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight

Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight

  • $ 5 369
  • Industry report
  • March 2014
  • by Firstword Pharma

Change is coming to the NSCLC treatment algorithm—and it's coming soon. Revolutionary new immunotherapies, more personalised treatment choices and further drug developments are all set to roll out in ...

  • Industries : Pathology
  • Countries : United States
Product and Pipeline Assessment of the Global Orphan Drugs Market

Product and Pipeline Assessment of the Global Orphan Drugs Market

  • $ 5 000
  • Industry report
  • February 2014
  • by Frost & Sullivan

Attractive Market Lures Hundreds of Innovators, Large and Small Executive Summary •The US National Institute of Health (NIH) currently recognizes more than xx orphan diseases, approximately xx of which ...

  • Industries : Pathology
  • Countries : World, United States
PharmaPoint: Schizophrenia - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - Japan Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - Japan Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core ...

  • Industries : Pathology
  • Countries : Japan
PharmaPoint: Schizophrenia - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - US Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - US Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, ...

  • Industries : Pathology
  • Countries : United States
Breast Cancer: New targeted therapies transform treatment - KOL Insight

Breast Cancer: New targeted therapies transform treatment - KOL Insight

  • $ 4 995
  • Industry report
  • February 2014
  • by Firstword Pharma

Introduction The introduction of targeted therapies revolutionised the breast cancer market, widening clinical options and bringing improved survival rates and lower side effects for patients. Now the ...

  • Industries : Pathology
  • Countries : United States
Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • March 2014
  • by Transparency Market Research

A rise in the world's aging population, increase in the number of patients living with Parkinson's disease and growing awareness about neurological movement disorders among patients have triggered the ...

  • Industries : Pathology
  • Countries : World
Global Infectious Diseases Therapeutics Market—Influenza, RSV, Chlamydia, and Gonorrhoea

Global Infectious Diseases Therapeutics Market—Influenza, RSV, Chlamydia, and Gonorrhoea

  • $ 4 500
  • Industry report
  • February 2014
  • by Frost & Sullivan

Persistent Unmet Need for Treatment Fuels Novel Antiviral/Antibacterial Drug Development RSV Antivirals • Ribavirin, the only approved antiviral directed at the human respiratory syncytial virus (RSV), ...

  • Industries : Pathology
  • Countries : World
EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • April 2014
  • by Global Data

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023 Summary Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, United States, United Kingdom
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2014
  • by Global Data

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022 Summary Ankylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, ...

  • Industries : Pathology
  • Countries : World, United States, Japan, Europe, Sweden, Spain, Italy, France, Germany, Finland
EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2014
  • by Global Data

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023 Summary Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of ...

  • Industries : Pathology
  • Countries : World, Australia, Spain, Italy, France, Germany, Japan
EpiCast Report: Migraine - Epidemiology Forecast to 2023

EpiCast Report: Migraine - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2014
  • by Global Data

EpiCast Report: Migraine - Epidemiology Forecast to 2023 Summary Migraine is typically characterized by recurring headaches, throbbing pain on one side of the head along with one or more of the following ...

  • Industries : Pathology
  • Countries : World, Japan, United States, Spain, Italy, France, Germany
Analytical Tool - Melanoma

Analytical Tool - Melanoma

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Melanoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in melanoma R&D and business development. It is at the same time a map of the ...

  • Industries : Pathology
Analytical Tool - Pancreatic Cancer

Analytical Tool - Pancreatic Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at the same ...

  • Industries : Pathology
Analytical Tool - Prostate Cancer

Analytical Tool - Prostate Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development. It is at the same time ...

  • Industries : Pathology
Analytical Tool - Breast Cancer

Analytical Tool - Breast Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time a ...

  • Industries : Pathology
Analytical Tool - Colorectal Cancer

Analytical Tool - Colorectal Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development. It is at the same ...

  • Industries : Pathology
Analytical Tool - Leukemia

Analytical Tool - Leukemia

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Leukemia" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in leukemia R&D and business development. It is at the same time a map of the ...

  • Industries : Pathology
Analytical Tool - Lung Cancer

Analytical Tool - Lung Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Drug Pipeline Update 2014". According ...

  • Industries : Pathology
Analytical Tool - Lymphoma

Analytical Tool - Lymphoma

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

Executive Summary "Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map ...

  • Industries : Pathology
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool

NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool

  • $ 3 500
  • Industry report
  • March 2014
  • by GBI Research

NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool Summary GBI Research, the leading business intelligence ...

  • Industries : Pathology
  • Countries : World
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth

  • $ 3 500
  • Industry report
  • February 2014
  • by GBI Research

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth Summary GBI Research, a leading business intelligence provider, ...

  • Industries : Pathology
  • Countries : World

» View Public Reports

About 12 000 reports

The Australian Pharmaceutical Business Brief

  • Industry report
  • April 2014
  • 8 pages
  • by Corporation

... To compare the expenditure of other chronic diseases, particularly chronic diseases that share many of the same risk factors such as ckd [14]. As a result, this investigation will determine and compare ...

U.s. Diabete Sector

April 2014

» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.